Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
CME
CME Group
$264.67
Login to see CME Group (CME) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Trading below its fair value
Upgraded on attractively valued
Earnings are forecast to grow
Chart
$261.53 (+1.20%)
$277.06 (-4.47%)
$267.06 (-0.89%)
$228.32 (+15.92%)
CME has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
CME overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Revenue increase YoY
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Trading below its fair value
Earnings are forecast to grow
CME Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CME Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayCME Earnings
The TTM reflects 12-month period, providing review of CME financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is CME current stock price?
What are CME stock strengths?
What risks are associated with CME stock?
When is CME next earnings report?
What is CME market cap and volume?
What is CME's current Stock IQ?
Should I buy CME stock right now?
Is CME a Strong Buy right now?
What does a 'Strong Buy' rating mean for CME?
What does a 'Strong Sell' rating mean for CME?
What factors influence CME's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
CME
CME Group
Current Price
$264.67
Stock Insights
Strengths
Trading below its fair value
Upgraded on attractively valued
Earnings are forecast to grow
Login to unlock CME Group (CME) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$261.53 (+1.20%)
$277.06 (-4.47%)
$267.06 (-0.89%)
$228.32 (+15.92%)
CME Analysts Opinion
CME Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Revenue increase YoY
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future
Trading below its fair value
Earnings are forecast to grow
CME Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
CME Street view is extremely bullish and have positive views on the near-term outlook
CME has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayCME Earnings
The TTM data reflects the most recent 12-month period, providing overview of CME financial performance.
CME Financial Health
The company financial health has moderately improved over the past year
Financial Score
CME Latest Analysis
Morgan Stanley Maintains CME Group (CME) Overweight Recommendation. Fintel reports that on October 1 2025 Morgan Stanley maintained coverage of CME Group (NasdaqGS:CME) with a Overweight recommendation. Analyst Price Forecast Suggests 9.92% Upside
Thu Oct 2, 2025
CME Outperforms Industry Trades at a Discount: How to Play the Stock. Solid global presence a compelling product portfolio increased electronic trading and a focus on over-the-counter clearing services poise CME Group for growth.
Fri Sep 26, 2025
JP Morgan Maintains CME Group (CME) Underweight Recommendation. Fintel reports that on September 25 2025 JP Morgan maintained coverage of CME Group (NasdaqGS:CME) with a Underweight recommendation. Analyst Price Forecast Suggests 8.08% Upside
Fri Sep 26, 2025
Citigroup Upgrades CME Group (CME). Fintel reports that on September 25 2025 Citigroup upgraded their outlook for CME Group (NasdaqGS:CME) from Neutral to Buy. Analyst Price Forecast Suggests 9.86% Upside
Thu Sep 25, 2025
CME Group upgraded at Citi on numerous catalysts ahead.
Thu Sep 25, 2025
CME Group: The Case Remains Compelling.
Tue Sep 16, 2025
CME Group: A Great Business But Not At A Cheap Enough Price.
Tue Sep 16, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings